Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Armand, Philippe
1700  Ergebnisse:
Personensuche X
?
1

Comparison of whole‐genome and immunoglobulin‐based circula..:

Merryman, Reid W. ; Rhoades, Justin ; Xiong, Kan...
HemaSphere.  8 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Five-year follow-up of a phase 2 study of ibrutinib plus fl..:

Ahn, Inhye E. ; Brander, Danielle M. ; Ren, Yue...
Blood Advances.  8 (2024)  4 - p. 832-841 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Safety profile of pembrolizumab monotherapy based on an agg..:

Brahmer, Julie R. ; Long, Georgina V. ; Hamid, Omid...
European Journal of Cancer.  199 (2024)  - p. 113530 , 2024
Link: https://doi.org/10.1016/..
 
?
4

A multi-cohort phase 1b trial of rituximab in combination w..:

Merryman, Reid W. ; Redd, Robert A. ; Freedman, Arnold S....
Annals of Hematology.  , 2023
Link: https://doi.org/10.1007/..
 
?
5

Minimal residual disease in patients with diffuse large B-c..:

Merryman, Reid W. ; Redd, Robert A. ; Taranto, Eleanor...
Blood Advances.  7 (2023)  17 - p. 4748-4759 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Interim Positron Emission Tomography During Frontline Chemo..:

Merryman, Reid W. ; Michaud, Laure ; Redd, Robert...
HemaSphere.  7 (2023)  2 - p. e826 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Clinical efficacy and safety of chimeric antigen receptor T..:

Ryan, Christine E. ; Zon, Rebecca L. ; Redd, Robert...
British Journal of Haematology.  203 (2023)  5 - p. 774-780 , 2023
Link: https://doi.org/10.1111/..
 
?
8

P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN..:

Armand, Philippe ; Luigi Zinzani, Pier ; Timmerman, John...
HemaSphere.  7 (2023)  S3 - p. e8856772 , 2023
Link: https://doi.org/10.1097/..
 
?
9

Nivolumab for relapsed/refractory classical Hodgkin lymphom..:

Ansell, Stephen M. ; Bröckelmann, Paul J. ; von Keudell, Gottfried...
Blood Advances.  7 (2023)  20 - p. 6266-6274 , 2023
Link: https://doi.org/10.1182/..
 
?
10

Brentuximab vedotin plus doxorubicin and dacarbazine in non..:

Abramson, Jeremy S. ; Bengston, Elizabeth ; Redd, Robert...
Blood Advances.  7 (2023)  7 - p. 1130-1136 , 2023
Link: https://doi.org/10.1182/..
 
?
11

Circulating Th17 T cells at treatment onset predict autoimm..:

Gadi, Deepti ; Martindale, Stephen P. ; Chiu, Pui Yan...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Prognostic value of early positron emission tomography in p..:

Crombie, Jennifer L. ; Jacobson, Caron A. ; Redd, Robert...
Haematologica.  108 (2023)  12 - p. 3433-3437 , 2023
Link: https://doi.org/10.3324/..
 
?
13

Mosunetuzumab in combination with CHOP in previously untrea..:

Olszewski, Adam J. ; Phillips, Tycel J. ; Hoffmann, Marc S....
Blood Advances.  7 (2023)  20 - p. 6055-6065 , 2023
Link: https://doi.org/10.1182/..
 
?
14

Pembrolizumab in Relapsed or Refractory Primary Mediastinal..:

Zinzani, Pier Luigi ; Thieblemont, Catherine ; Melnichenko, Vladimir...
Blood Journal.  , 2023
Link: https://doi.org/10.1182/..
 
?
15

P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY O..:

Johnson, Nathalie ; Lavie, David ; Borchmann, Peter...
HemaSphere.  7 (2023)  S3 - p. e0274602 , 2023
Link: https://doi.org/10.1097/..
 
1-15